Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

Experts presenting the findings today at the American Society for Clinical Oncology conference (ASCO) in Chicago hailed it a ...

Asad Haider, head of the healthcare business unit within Goldman Sachs Research, now forecasts the market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, to ...

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Johnson & Johnson announced today new data from a Phase 1 study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific antibody that activates T-cells to harness the body's immune system ...